Literature DB >> 9554701

Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.

A Pascale1, S Govoni, F Battaini.   

Abstract

Brain aging is characterized by a progressive decline of the cognitive and memory functions. It is becoming increasingly clear that protein phosphorylation and, in particular, the activity of the calcium-phospholipid-dependent protein kinase C (PKC) may be one of the fundamental cellular changes associated with memory function. PKC is a multigene family of enzymes highly expressed in brain tissues. The activation of kinase C is coupled with its translocation from the cytosol to different intracellular sites and recent studies have demonstrated the key role played by several anchoring proteins in this mechanism. PKC-phosphorylating activity appears to be impaired during senescence at brain level in a strain-dependent fashion in rodents. Whereas the levels of the various isoforms do not show age-related alterations, the enzyme translocation upon phorbol-ester treatment is deficitary among all strains investigated. Anchoring proteins may contribute to this activation deficit. We discuss also modifications of the PKC system in Alzheimer's disease that may be related to pathological alterations in neurotransmission. A better insight of the different factors controlling brain-PKC activation may be important not only for elucidating the molecular basis of neuronal transmission, but also for identifying new approaches for correcting or even preventing age-dependent changes in brain function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554701     DOI: 10.1007/BF02740602

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  104 in total

1.  Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation.

Authors:  S Govoni; S Bergamaschi; L Gasparini; C Quaglia; M Racchi; E Cattaneo; G Binetti; A Bianchetti; F Giovetti; F Battaini; M Trabuechi
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

2.  Imaging of memory-specific changes in the distribution of protein kinase C in the hippocampus.

Authors:  J L Olds; M L Anderson; D L McPhie; L D Staten; D L Alkon
Journal:  Science       Date:  1989-08-25       Impact factor: 47.728

Review 3.  Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity.

Authors:  H Manev; E Costa; J T Wroblewski; A Guidotti
Journal:  FASEB J       Date:  1990-07       Impact factor: 5.191

4.  Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals.

Authors:  K Ueda; S Shinohara; T Yagami; K Asakura; K Kawasaki
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

5.  Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.

Authors:  H Matsushima; S Shimohama; M Chachin; T Taniguchi; J Kimura
Journal:  J Neurochem       Date:  1996-07       Impact factor: 5.372

6.  C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo.

Authors:  D Ron; J Luo; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

7.  Alzheimer and beta-amyloid-treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20.

Authors:  C S Kim; Y F Han; R Etcheberrigaray; T J Nelson; J L Olds; T Yoshioka; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  An age-related spatial learning deficit: choline uptake distinguishes "impaired" and "unimpaired" rats.

Authors:  M Gallagher; M A Pelleymounter
Journal:  Neurobiol Aging       Date:  1988 Jul-Aug       Impact factor: 4.673

Review 9.  Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.

Authors:  L W Jin; T Saitoh
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

10.  Secretory processing of the Alzheimer amyloid beta/A4 protein precursor is increased by protein phosphorylation.

Authors:  S L Gillespie; T E Golde; S G Younkin
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

View more
  21 in total

1.  Calcineurin links Ca2+ dysregulation with brain aging.

Authors:  T C Foster; K M Sharrow; J R Masse; C M Norris; A Kumar
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Calcium induces expression of cytoplasmic gelsolin in SH-SY5Y and HEK-293 cells.

Authors:  Lina Ji; Abha Chauhan; Ved Chauhan
Journal:  Neurochem Res       Date:  2010-03-26       Impact factor: 3.996

3.  Differential recruitment of PKC isoforms in HeLa cells during redox stress.

Authors:  Alessandro Rimessi; Rosario Rizzuto; Paolo Pinton
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

4.  Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.

Authors:  Mamta Behl; Yanshu Zhang; Yunzhou Shi; Jixin Cheng; Yansheng Du; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-05-19       Impact factor: 4.294

Review 5.  Molecular and cellular aspects of age-related cognitive decline and Alzheimer's disease.

Authors:  Rikki Hullinger; Luigi Puglielli
Journal:  Behav Brain Res       Date:  2016-05-07       Impact factor: 3.332

6.  Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death.

Authors:  Huajun Jin; Arthi Kanthasamy; Vellareddy Anantharam; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

7.  Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains.

Authors:  Miao-Kun Sun; Jarin Hongpaisan; Thomas J Nelson; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

8.  Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Authors:  René Etcheberrigaray; Mathew Tan; Ilse Dewachter; Cuno Kuipéri; Ingrid Van der Auwera; Stefaan Wera; Lixin Qiao; Barry Bank; Thomas J Nelson; Alan P Kozikowski; Fred Van Leuven; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

Review 9.  Neurotoxic effects and biomarkers of lead exposure: a review.

Authors:  Talia Sanders; Yiming Liu; Virginia Buchner; Paul B Tchounwou
Journal:  Rev Environ Health       Date:  2009 Jan-Mar       Impact factor: 3.458

10.  The selective inhibition of nuclear PKCζ restores the effectiveness of chemotherapeutic agents in chemoresistant cells.

Authors:  Alessandro Rimessi; Erika Zecchini; Roberta Siviero; Carlotta Giorgi; Sara Leo; Rosario Rizzuto; Paolo Pinton
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.